RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers
- PMID: 32745900
- DOI: 10.1016/j.oraloncology.2020.104930
RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers
Abstract
Mutations in histone modifying enzymes and histone variants were identified in multiple cancers in The Cancer Genome Atlas (TCGA) studies. However, very little progress and understanding has been made in identifying the contribution of epigenetic factors in head and neck squamous cell carcinoma (HNSCC). Here, we report the identification of RUVBL1 (TIP49a), a component of the TIP60 histone modifying complex as being amplified and overexpressed in HNSCC. RUVBL1 plays a key role in incorporating histone variant H2AZ in chromatin thereby regulating transcription of key genes involved in differentiation, cancer cell proliferation and invasion. H2AZ is also overexpressed in HNSCC tumors thereby regulating RUVBL1/H2AZ dependent transcriptional programs. Patient data analysis of multiple cohorts including TCGA and single cell HNSCC data indicated RUVBL1 overexpression as a poor prognostic marker and predicts poor survival. In vitro experiments indicate a pro-proliferative role for RUVBL1/H2AZ in HNSCC cells. RUVBL1 inversely correlates with differentiation program and positively correlates with oncogenic programs, making it a key contributor to tumorigenesis and a vulnerable therapeutic target in HNSCC patients.
Keywords: H2AZ; Head and Neck Squamous Cell Carcinoma (HNSCC); RUVBL1 (Tip49a); RUVBL2; The Cancer Genome Atlas (TCGA), Cyto-Keratins.
Copyright © 2020. Published by Elsevier Ltd.
Similar articles
-
Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.BMC Cancer. 2021 Nov 12;21(1):1205. doi: 10.1186/s12885-021-08868-4. BMC Cancer. 2021. PMID: 34772357 Free PMC article.
-
Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma.Dis Markers. 2022 Apr 22;2022:3398492. doi: 10.1155/2022/3398492. eCollection 2022. Dis Markers. 2022. PMID: 35493294 Free PMC article.
-
CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.Mol Cancer. 2019 Oct 29;18(1):150. doi: 10.1186/s12943-019-1076-1. Mol Cancer. 2019. PMID: 31665067 Free PMC article.
-
Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.Epigenomics. 2022 Mar;14(5):279-293. doi: 10.2217/epi-2020-0348. Epub 2022 Feb 21. Epigenomics. 2022. PMID: 35184601 Review.
-
Epigenetic Modifications in Head and Neck Cancer.Biochem Genet. 2020 Apr;58(2):213-244. doi: 10.1007/s10528-019-09941-1. Epub 2019 Nov 11. Biochem Genet. 2020. PMID: 31712935 Free PMC article. Review.
Cited by
-
A Systematic Analysis Reveals the Prognostic and Immunological Role of Reptin/RUVBL2 in Human Tumors.Front Genet. 2022 Jun 8;13:911223. doi: 10.3389/fgene.2022.911223. eCollection 2022. Front Genet. 2022. PMID: 35754815 Free PMC article.
-
Molecular Signatures of CB-6644 Inhibition of the RUVBL1/2 Complex in Multiple Myeloma.Int J Mol Sci. 2024 Aug 20;25(16):9022. doi: 10.3390/ijms25169022. Int J Mol Sci. 2024. PMID: 39201707 Free PMC article.
-
RUVBL1 accelerates tongue squamous cell carcinoma by mediating CRaf/MEK/ERK pathway.iScience. 2024 Mar 6;27(4):109434. doi: 10.1016/j.isci.2024.109434. eCollection 2024 Apr 19. iScience. 2024. PMID: 38523780 Free PMC article.
-
High copy number variations, particular transcription factors, and low immunity contribute to the stemness of prostate cancer cells.J Transl Med. 2021 May 13;19(1):206. doi: 10.1186/s12967-021-02870-x. J Transl Med. 2021. PMID: 33985534 Free PMC article.
-
Rvb1/Rvb2 proteins couple transcription and translation during glucose starvation.Elife. 2022 Sep 15;11:e76965. doi: 10.7554/eLife.76965. Elife. 2022. PMID: 36107469 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous